<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33408239</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-330X</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Effect of familial clustering in the genetic screening of 235 French ALS families.</ArticleTitle><Pagination><StartPage>479</StartPage><EndPage>484</EndPage><MedlinePgn>479-484</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2020-325064</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To determine whether the familial clustering of amyotrophic lateral sclerosis (ALS) cases and the phenotype of the disease may help identify the pathogenic genes involved.</AbstractText><AbstractText Label="METHODS">We conducted a targeted next-generation sequencing analysis on 235 French familial ALS (FALS), unrelated probands to identify mutations in 30 genes linked to the disease. The genealogy, that is, number of cases and generations with ALS, gender, age, site of onset and the duration of the disease were analysed.</AbstractText><AbstractText Label="RESULTS">Regarding the number of generations, 49 pedigrees had only one affected generation, 152 had two affected generations and 34 had at least three affected generations. Among the 149 pedigrees (63.4%) for which a deleterious variant was found, an abnormal G4C2 expansion in <i>C9orf72</i> was found in 98 cases as well as <i>SOD1</i>, <i>TARBP</i> or <i>FUS</i> mutations in 30, 9 and 7 cases, respectively. Considering pedigrees from the number of generations, abnormal G4C2 expansion in <i>C9orf72</i> was more frequent in pedigrees with pairs of affected ALS cases, which represented 65.2% of our cohort. <i>SOD1</i> mutation involved all types of pedigrees. No <i>TARDBP</i> nor <i>FUS</i> mutation was present in monogenerational pedigrees. <i>TARDBP</i> mutation predominated in bigenerational pedigrees with at least three cases and <i>FUS</i> mutation in multigenerational pedigrees with more than seven cases, on average, and with an age of onset younger than 45 years.</AbstractText><AbstractText Label="CONCLUSION">Our results suggest that familial clustering, phenotypes and genotypes are interconnected in FALS, and thus it might be possible to target the genetic screening from the familial architecture and the phenotype of ALS cases.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corcia</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1625-8845</Identifier><AffiliationInfo><Affiliation>ALS Centre, Department of Neurology, CHU Tours, Tours, Centre, France corcia@med.univ-tours.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR 1253 Imaging and Brain, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camu</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Montpellier 2 University, Montpellier, Languedoc-Roussillon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brulard</LastName><ForeName>Celine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UMR 1253 Imaging and Brain, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marouillat</LastName><ForeName>Sylviane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UMR 1253 Imaging and Brain, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ALS Center, Departement of neurology, CHU Limoges, Limoges, Limousin, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR-S 1094 NET, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camdessanch&#xe9;</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-5282-6707</Identifier><AffiliationInfo><Affiliation>Neurology, Saint-Etienne University Hospital Bellevue Site, Saint-Etienne, Rh&#xf4;ne-Alpes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cintas</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Neurology, CHU Toulouse, Toulouse, Midi-Pyr&#xe9;n&#xe9;es, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verschueren</LastName><ForeName>Annie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence des maladies neuromusculaires et de la SLA, Marseille Public University Hospital System, Marseille, Provence-Alpes-C&#xf4;te d'Azu, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soriani</LastName><ForeName>Marie-Helene</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>CHU Nice, Nice, Provence-Alpes-C&#xf4;te d'Azu, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desnuelle</LastName><ForeName>Claude</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre de reference des maladies neuromusculaires SLA, Neurosciences department, CHU Nice, Nice, Provence-Alpes-C&#xf4;te d'Azu, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleury</LastName><ForeName>Marie-C&#xe9;line</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Neurology, CHU Strasbourg, Strasbourg, Alsace, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guy</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CHU Clermont-Ferrand, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassereau</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurology, CHU Angers, Angers, Pays de la Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viader</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>U1077, INSERM, Paris, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pittion-Vouyovitch</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology, Hopital Central, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danel</LastName><ForeName>Veronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Medical Pharmacology, Lille University Hospital Center, Lille, Hauts-de-France, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolev</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hospital Centre Saint Brieuc, Saint Brieuc, Bretagne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Masson</LastName><ForeName>Gwendal</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurology, Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin, Bordeaux, Aquitaine, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltran</LastName><ForeName>Stephane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ALS Center, Francois-Rabelais University, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salachas</LastName><ForeName>Francois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ALS Center, Neurology, Hopital Universitaire Pitie Salpetriere, Paris, &#xce;le-de-France, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernard</LastName><ForeName>Emilien</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Hospital Centre Lyon, Lyon, Auvergne-Rh&#xf4;ne-Alpes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradat</LastName><ForeName>Pierre-Fran&#xe7;ois</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>F&#xe9;d&#xe9;ration de Neurologie, Centre R&#xe9;f&#xe9;rent SLA, Hopital Universitaire Pitie Salpetriere, Paris, &#xce;le-de-France, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale (LIB), Universit&#xe9; Pierre et Marie Curie Facult&#xe9; de M&#xe9;decine, Paris, &#xce;le-de-France, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasco</LastName><ForeName>H&#xe9;l&#xe8;ne</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6107-0035</Identifier><AffiliationInfo><Affiliation>Biochemistry and Molecular Biology Department, Universit&#xe9; Francois-Rabelais de Tours, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurogenetics and Neurometabolomics, Imagerie et cerveau, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanznaster</LastName><ForeName>D&#xe9;bora</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5911-3120</Identifier><AffiliationInfo><Affiliation>UMR 1253 Imaging and Brain, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hergesheimer</LastName><ForeName>Rudolph</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UMR 1253 Imaging and Brain, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laumonnier</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UMR 1253 Imaging and Brain, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andres</LastName><ForeName>Christian R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Biochemistry and Molecular Biology Department, Universit&#xe9; Francois-Rabelais de Tours, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meininger</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neurogenetics and Neurometabolomics, Imagerie et cerveau, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vourc'h</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biochemistry and Molecular Biology Department, Universit&#xe9; Francois-Rabelais de Tours, Tours, Centre-Val de Loire, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33408239</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2020-325064</ArticleId><ArticleId IdType="pii">jnnp-2020-325064</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>